Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2021 Financial Results
July 15 2021 - 4:01PM
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage
biopharmaceutical company dedicated to the development of
programmed cellular immunotherapies for cancer, today announced
that the Company will host a conference call and live audio webcast
on Wednesday, August 4, 2021 at 5:00 p.m. ET to
report its second quarter 2021 financial results and provide a
corporate update.
In order to participate in the conference call,
please dial 800-773-2954 (toll free) or 847-413-3731 (toll) and
refer to confirmation number 50196101. The live webcast can be
accessed under "Events & Presentations" in the Investors
section of the Company's website at www.fatetherapeutics.com.
The archived webcast will be available on the Company's website
beginning approximately two hours after the event.
About Fate Therapeutics,
Inc.Fate Therapeutics is a clinical-stage
biopharmaceutical company dedicated to the development of
first-in-class cellular immunotherapies for patients with cancer.
The Company has established a leadership position in the clinical
development and manufacture of universal, off-the-shelf cell
products using its proprietary induced pluripotent stem cell (iPSC)
product platform. The Company’s immuno-oncology pipeline includes
off-the-shelf, iPSC-derived natural killer (NK) cell and T-cell
product candidates, which are designed to synergize with
well-established cancer therapies, including immune checkpoint
inhibitors and monoclonal antibodies, and to target
tumor-associated antigens using chimeric antigen receptors (CARs).
Fate Therapeutics is headquartered in San Diego, CA. For more
information, please visit www.fatetherapeutics.com.
Contact:Christina TartagliaStern
Investor Relations, Inc.212.362.1200christina@sternir.com
Fate Therapeutics (NASDAQ:FATE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fate Therapeutics (NASDAQ:FATE)
Historical Stock Chart
From Sep 2023 to Sep 2024